HeartSciences (HSCS) Cash from Operations (2021 - 2026)

HeartSciences (HSCS) has reported Cash from Operations for 6 consecutive years, with 1676548.0 the latest figure, recorded in Q2 2026.

• Quarterly Cash from Operations fell 5.4% year-over-year to 1676548.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 7554821.0 (down 1.91% YoY) and the FY2026 annual result came in at 7426707.0, changed 0.18% from the prior year.
• Cash from Operations grew to 1676548.0 in Q2 2026 per HSCS's latest filing, from 2334266.0 in the prior quarter.
• Over the last five years, Cash from Operations for HSCS reached as high as 966278.0 in Q1 2022 and fell as low as 2334266.0 in Q4 2025.
• A 5-year average of 1610561.0 and a median of 1620084.0 in 2025 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2022 — Cash from Operations plunged 152.51% — and 2025, when it climbed 22.89%.
• Year by year, Cash from Operations stood at 1080141.0 in 2022, then increased by 8.51% to 988187.0 in 2023, then plunged by 120.97% to 2183550.0 in 2024, then dropped by 6.9% to 2334266.0 in 2025, then grew by 28.18% to 1676548.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 1676548.0, 2334266.0, and 1953367.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.